In order to support the anticipated launch and commercialization of Prosoma’s digital therapy to support the mental health of cancer patients, the company has partnered with EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry. Prosoma Digital Therapeutics is an innovator in reinventing healthcare for oncology patients.
The business’s unique digital therapy, Living Well, is intended to enhance quality of life and lessen symptoms of stress, anxiety, and depression associated with cancer diagnosis and treatment. Prosoma will get assistance from EVERSANA’s top professionals in establishing and commercializing digital therapeutic solutions as it navigates regulatory frameworks and makes commercialization plans.
“As we looked to navigate the complexity of commercializing our digital solutions in the United States, it became clear we need a partner with the infrastructure and experience to help us move quickly”, “As we spoke with partners across Europe and the world, one name continued to rise to the top and that was EVERSANA. Their integrated platform and deep experience in digital therapeutics make them the perfect partner to help bring our important therapies to patients.”
Andrzej Jonczyk, Chief Executive Officer, Prosoma U.S.
“The future of healthcare continues to evolve as innovative solutions improve the patient journey”, “EVERSANA was built with this in mind. By helping Prosoma, we will provide critical mental health support for cancer patients and caregivers through this novel approach to digital therapy.”
Jim Lang, CEO, EVERSANA